Form 8-K - Current report:
SEC Accession No. 0001493152-24-047421
Filing Date
2024-11-22
Accepted
2024-11-22 16:45:12
Documents
15
Period of Report
2024-11-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47111
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 14040
  Complete submission text file 0001493152-24-047421.txt   291105

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocea-20241118.xsd EX-101.SCH 3509
4 XBRL DEFINITION FILE ocea-20241118_def.xml EX-101.DEF 29931
5 XBRL LABEL FILE ocea-20241118_lab.xml EX-101.LAB 36433
6 XBRL PRESENTATION FILE ocea-20241118_pre.xml EX-101.PRE 26954
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5601
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 241490489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)